Generics and Biosimilars Initiative Journal

Apply

Generics and Biosimilars Initiative Journal

Print ISSN: 2033-6403, 2033-6772

Electronic ISSN: None

Basic Info

Publisher: Lasia Tang
Country: belgium
Date added to EuroPub 2019/Sep/29

Subject & More

LCC Subject Category:

Publisher's keywords:

Language of fulltext:
Time from submission to publication: Weeks

Publication Charges

Article Processing Charges (APCs): No
Submission charges: No
Waiver policy for charges? No

Open access & licensing

Type of License:
Open Access Statement: No
Year open access content began: 2012
Does the author retain unrestricted copyright? False
Does the author retain publishing rights? False

Best practice polices

Permanent article identifier:
Content digitally archived in:
Deposit policy registered in:

Impact Factor

Drug shortages hit US oncologists hard

Journal title: Generics and Biosimilars Initiative Journal

Authors: GaBI Journal Editor

Subject(s):

Editor’s introduction to the initial issue of the third volume of GaBI Journal

Journal title: Generics and Biosimilars Initiative Journal

Authors: Philip D Walson

Subject(s):

Common or distinct INN for biosimilars? Only characteristics of the active substance prior to formulation should be considered

Journal title: Generics and Biosimilars Initiative Journal

Authors: Paul J Declerck

Subject(s):

Biosimilar monoclonal antibodies approved for use in the EU

Journal title: Generics and Biosimilars Initiative Journal

Authors: Meenu Wadhwa, Robin Thorpe

Subject(s):

The biosimilar name debate: what’s at stake for public health

Journal title: Generics and Biosimilars Initiative Journal

Authors: Emily A Alexander

Subject(s):

Alternative statistical strategies for biosimilar drug development

Journal title: Generics and Biosimilars Initiative Journal

Authors: Austin J Combest, Song Wang, Brian T Healey, Dirk J Reitsma

Subject(s):

Statistical considerations for the development of biosimilar products

Journal title: Generics and Biosimilars Initiative Journal

Authors: Nan Zhang, Eric Chi

Subject(s):

Assuring patient-centred care: engaging patients with rheumatoid arthritis in disease monitoring and pharmacovigilance

Journal title: Generics and Biosimilars Initiative Journal

Authors: Janet S Wyatt

Subject(s):

New product-specific bioequivalence guidance

Journal title: Generics and Biosimilars Initiative Journal

Authors: Christoph Baumgärtel

Subject(s):

First Asia-Pacific educational workshop on non-biological complex drugs (NBCDs), Kuala Lumpur, Malaysia, 8 October 2013

Journal title: Generics and Biosimilars Initiative Journal

Authors: Philip D Walson, Stefan Mühlebach, Beat Flühmann

Subject(s):

Analysis of European policy towards generic medicines

Journal title: Generics and Biosimilars Initiative Journal

Authors: Pieter Dylst, Arnold G Vulto, Steven Simoens

Subject(s):

Biosimilarity of anticancer monoclonal antibodies in the clinic

Journal title: Generics and Biosimilars Initiative Journal

Authors: GaBI Journal Editor

Subject(s):

Top developments in biosimilars during 2013

Journal title: Generics and Biosimilars Initiative Journal

Authors: GaBI Journal Editor

Subject(s):

What to look forward to in GaBI Journal, 2014, Issue 2

Journal title: Generics and Biosimilars Initiative Journal

Authors: Philip D Walson

Subject(s):

Complex molecules – current developments

Journal title: Generics and Biosimilars Initiative Journal

Authors: Gerrit Borchard

Subject(s):